image: Artwork depicting the mechanism for the human cytomegalovirus (HCMV) vaccine developed by Dai Wang et al. This material relates to a paper that appeared in the Oct. 26, 2016, issue of Science Translational Medicine, published by AAAS. The paper, by D. Wang at Merck and Co. Inc in Kenilworth, NJ, and colleagues was titled, 'A replication-defective human cytomegalovirus vaccine for prevention of congenital infection.' view more
Credit: lili scientific artwork